Wednesday, May 24, 2017 12:48:25 PM
That was stated emphatically many times. Yes there was some talk of still reaching out to manufactures from time-to-time but so what.
The reference from the Annual report couldn't be clearer and should put an end to the discussion once and for all. Statements that the company has never communicated the demise of the cell are not based in reality.
Like it or not - the move away from the cell to installations has kept this stock from being pure speculation and has been good for longs who originally invested only because of the potential of the cell.
Never argue with a fool, onlookers may not be able to tell the difference. - Mark Twain
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM